Literature DB >> 6426148

Immunohistochemical reactivity of a monoclonal antibody prepared against human breast carcinoma.

R Mariani-Costantini, M I Colnaghi, F Leoni, S Mènard, S Cerasoli, F Rilke.   

Abstract

The reactivity profile of an IgM monoclonal antibody, MBR1 , raised against the human breast cancer cell line MCF7 , was studied in a variety of human tumours and non-neoplastic tissues by light microscopic immunohistochemistry. The range of reactivity included specific types of non-neoplastic epithelial cells and a number of epithelial tumours. Most mammary carcinomas reacted with MBR1 , but adenocarcinomas and squamous carcinomas from different sites were also strongly positive. Different patterns of immunoreactivity were apparent in microscopically normal tissues, in tissues with inflammatory changes and in carcinomas. Heterogeneous staining, despite morphological similarities, was documented in neoplastic and non-neoplastic epithelial cells. The reactivity of MBR1 was different from that reported for other monoclonal antibodies, but revealed similarities to that of monoclonal antibodies and polyclonal sera against human milk fat globule membrane.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6426148     DOI: 10.1007/bf00734636

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  31 in total

1.  A new antigen on the epithelial membrane: its immunoperoxidase localisation in normal and neoplastic tissue.

Authors:  E Heyderman; K Steele; M G Ormerod
Journal:  J Clin Pathol       Date:  1979-01       Impact factor: 3.411

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Use of monoclonal antibodies for the histopathological diagnosis of human malignancy.

Authors:  K C Gatter; Z Abdulaziz; P Beverley; J R Corvalan; C Ford; E B Lane; M Mota; J R Nash; K Pulford; H Stein; J Taylor-Papadimitriou; C Woodhouse; D Y Mason
Journal:  J Clin Pathol       Date:  1982-11       Impact factor: 3.411

4.  Molecular recognition and the future of monoclonal antibodies.

Authors:  D Lane; H Koprowski
Journal:  Nature       Date:  1982-03-18       Impact factor: 49.962

5.  Immunoperoxidase localization of a glycoprotein on plasma membrane of secretory epithelium from human breast.

Authors:  A Imam; Z A Tökés
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  Immunochemical analysis of the determinant recognized by a monoclonal antibody (MBr1) which specifically binds to human mammary epithelial cells.

Authors:  S Canevari; G Fossati; A Balsari; S Sonnino; M I Colnaghi
Journal:  Cancer Res       Date:  1983-03       Impact factor: 12.701

7.  A human breast tissue-associated antigen detected by a monoclonal antibody.

Authors:  C H Thompson; S L Jones; R H Whitehead; I F McKenzie
Journal:  J Natl Cancer Inst       Date:  1983-03       Impact factor: 13.506

8.  Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types.

Authors:  S E Kabawat; R C Bast; W R Welch; R C Knapp; R B Colvin
Journal:  Am J Clin Pathol       Date:  1983-01       Impact factor: 2.493

9.  Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers.

Authors:  J Arklie; J Taylor-Papadimitrious; W Bodmer; M Egan; R Millis
Journal:  Int J Cancer       Date:  1981-07-15       Impact factor: 7.396

10.  Heterogeneity of the natural humoral anti-tumor immune response in mice as shown by monoclonal antibodies.

Authors:  M I Colnaghi; S Menard; E Tagliabue; G D Torre
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

View more
  14 in total

1.  Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression.

Authors:  S Martignone; R Pellegrini; E Villa; N N Tandon; A Mastroianni; E Tagliabue; S Ménard; M I Colnaghi
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

2.  Tumour-associated antigens in mammary and extramammary Paget's disease.

Authors:  R Mariani-Costantini; S Andreola; F Rilke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

3.  Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate.

Authors:  V Kudryashov; G Ragupathi; I J Kim; M E Breimer; S J Danishefsky; P O Livingston; K O Lloyd
Journal:  Glycoconj J       Date:  1998-03       Impact factor: 2.916

4.  Epithelial markers for paraffin-embedded human tissues. Immunohistochemistry with monoclonal antibodies against milk fat globule antigens.

Authors:  S Zotter; A Lossnitzer; K D Kunze; M Müller; J Hilkens; J Hilgers; P Hageman
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

5.  Monoclonal antibodies against antigens on breast cancer cells.

Authors:  C Stähli; B Takacs; V Miggiano; T Staehelin; H Carmann
Journal:  Experientia       Date:  1985-11-15

6.  Immunohistochemical demonstration of MAM-3 and MAM-6 antigens in normal human skin appendages and their tumors.

Authors:  A Tsubura; S Morii; S Ueda; M Sasaki; S Zotter; V Watzig; W Mooi; P Hageman; J Hilkens; J Van den Tweel
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

7.  The immunohistochemical reactivity of a new anti-epithelial monoclonal antibody (MAb b-12) against breast carcinoma and other normal and neoplastic human tissues.

Authors:  H R Zenklusen; C Stähli; F Gudat; J von Overbeck; J Rolink; P U Heitz
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

8.  Recognition of galactosylgloboside by monoclonal antibodies derived from patients with primary lung cancer.

Authors:  D S Schrump; K Furukawa; H Yamaguchi; K O Lloyd; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  Immunoconjugate generation between the ribosome inactivating protein restrictocin and an anti-human breast carcinoma MAB.

Authors:  R Orlandi; S Canevari; F P Conde; F Leoni; D Mezzanzanica; M Ripamonti; M I Colnaghi
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

10.  Study of the biological and prognostic significance of the antigen CaMBr8 on breast carcinoma.

Authors:  P Facheris; F Perrone; S Ménard; S Andreola; P Bazzini; R Bufalino; S Canevari; N Cascinelli; E Colzani; G Di Fronzo
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.